ContextVision AB (publ) (OSL:CONTX)
Norway · Delayed Price · Currency is NOK 5.12
+0.40 (8.47%)
Sep 18, 2026, 4:27 PM CET
ContextVision AB Market Cap
ContextVision AB has a market cap or net worth of 381.49 million as of September 18, 2026. Its market cap has increased by 12.06% in one year.
Market Cap
381.49M
Enterprise Value
312.41M
Revenue
121.88M
Ranking
n/a
PE Ratio
28.62
Stock Price
5.12
ChartMarket Cap Chart
Since March 18, 1997, ContextVision AB's market cap has increased from 296.00M to 381.49M, an increase of 28.88%. That is a compound annual growth rate of 0.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 381.49M | 19.48% |
| Dec 30, 2025 | 319.30M | -24.96% |
| Dec 30, 2024 | 425.52M | -28.57% |
| Dec 29, 2023 | 595.73M | -15.75% |
| Dec 30, 2022 | 707.14M | -44.49% |
| Dec 30, 2021 | 1.27B | -25.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.50B |
| Circio Holding ASA | 3.25B |
| Thor Medical ASA | 2.00B |
| Nordhealth AS | 1.96B |
| Lytix Biopharma ASA | 645.96M |
| INIFY Laboratories AB | 644.85M |
| Gentian Diagnostics ASA | 609.07M |
| Zelluna ASA | 600.04M |